Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data and Trends in Adverse Drug ReactionsJeffrey K. Aronson Elsevier, 19/08/2011 - 714 páginas The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the Annuals by selecting critically from each year's writing all that is truly new and informative, by critically interpreting it, and by pointing to whatever is misleading.
|
Índice
| 1 | |
| 18 | |
| 28 | |
| 35 | |
Chapter 5 Hypnosedatives and anxiolytics | 51 |
Chapter 6 Antipsychotic drugs | 60 |
Chapter 7 Antiepileptic drugs | 87 |
Chapter 8 Opioid analgesics and narcotic antagonists | 105 |
Chapter 28 Antiprotozoal drugs | 294 |
Chapter 29 Antiviral drugs | 300 |
Chapter 30 Drugs used in tuberculosis and leprosy | 315 |
Chapter 31 Antihelminthic drugs | 320 |
Chapter 32 Vaccines | 327 |
Chapter 33 Blood blood components plasma and plasma products | 338 |
Chapter 34 Formulations used in nutrition | 353 |
Chapter 35 Drugs affecting blood coagulation fibrinolysis and hemostasis | 358 |
Chapter 9 Antiinflammatory and antipyretic analgesics and drugs used in gout | 116 |
Chapter 10 General anesthetics and therapeutic gases | 128 |
Chapter 11 Local anesthetics | 135 |
Chapter 12 Neuromuscular blocking agents and skeletal muscle relaxants | 145 |
Chapter 13 Drugs that affect autonomic functions or the extrapyramidal system | 148 |
Chapter 14 Dermatological drugs topical agents and cosmetics | 156 |
Chapter 15 Antihistamines H1 receptor antagonists | 161 |
Chapter 16 Drugs acting on the respiratory tract | 168 |
Chapter 17 Positive inotropic drugs and drugs used in dysrhythmias | 182 |
Chapter 18 Betaadrenoceptor antagonists and antianginal drugs | 194 |
Chapter 19 Drugs acting on the cerebral and peripheral circulations | 202 |
Chapter 20 Antihypertensive drugs | 206 |
Chapter 21 Diuretics | 219 |
Chapter 22 Metals | 225 |
Chapter 23 Metal antagonists | 235 |
Chapter 24 Antiseptic drugs and disinfectants | 241 |
Chapter 25 Penicillins cephalosporins other betalactam antibiotics and tetracyclines | 244 |
Chapter 26 Miscellaneous antibacterial drugs | 253 |
Chapter 27 Antifungal drugs | 280 |
Chapter 36 Gastrointestinal drugs | 371 |
cytokines and monoclonal antibodies | 383 |
immunosuppressive and immunostimulatory drugs | 424 |
Chapter 39 Corticotrophins corticosteroids and prostaglandins | 480 |
Chapter 40 Sex hormones and related compounds including hormonal contraceptives | 493 |
Chapter 41 Thyroid hormones and antithyroid drugs | 520 |
Chapter 42 Insulin other hypoglycemic drugs and glucagon | 523 |
Chapter 43 Miscellaneous hormones | 539 |
Chapter 44 Drugs that affect lipid metabolism | 546 |
Chapter 45 Cytostatic drugs | 551 |
Chapter 46 Radiological contrast agents | 573 |
Chapter 47 Drugs used in ocular treatment | 581 |
Chapter 48 Treatments used in complementary and alternative medicine | 583 |
Chapter 49 Miscellaneous drugs and materials medical devices and techniques | 596 |
Address list of national centres that participate in the WHO Drug Monitoring Programme | 618 |
| 632 | |
| 644 | |
Outras edições - Ver tudo
Side Effects of Drugs Annual 29: A Worldwide Yearly Survey of New Data and ... J. K. Aronson Pré-visualização indisponível - 2007 |
Palavras e frases frequentes
acid activity acute adverse drug reactions adverse effects adverse events allergic angioedema associated azathioprine blood cancer carbamazepine cardiac cardiovascular cause cell chronic ciclosporin Clin Pharmacol clinical clozapine cocaine combination compared concentrations coronary developed diabetes disease disorder dosage dose double-blind Drug interactions edema efficacy etanercept fects fluconazole function gastrointestinal glucocorticoids Hematologic hepatitis hormone hypertension incidence increased infection infliximab infusion inhaled inhibitors insulin interferon interferon alfa intravenous itraconazole kidney lamotrigine leflunomide linezolid lithium liver metabolism metformin methotrexate mg bd mg/day micrograms mmol/l months mycophenolate mofetil myocardial nausea occurred olanzapine oral overdose pain patients taking pharmacokinetics placebo placebo-controlled plasma propofol pulmonary randomized reactions receptor reduced regimens renal reported respiratory rheumatoid arthritis risk risperidone safety seizures serum significant significantly sirolimus skin sodium suggested Susceptibility factors symptoms syndrome tacrolimus Ther therapy tients tion toxicity treated treatment vaccine versus voriconazole weeks withdrawal woman women
Passagens conhecidas
Página xxxiv - Reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously. Usually more than a single report is required to generate a signal, depending on the seriousness of the event and the quality of the information.